+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Proton Therapy Market by Product, System Type, Therapy, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674719
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Proton Therapy Market grew from USD 511.83 million in 2023 to USD 562.24 million in 2024. It is expected to continue growing at a CAGR of 9.92%, reaching USD 992.42 million by 2030.

Proton therapy is an advanced form of radiation therapy that uses protons instead of X-rays to treat cancer, offering precision that minimizes damage to surrounding healthy tissues. The necessity for proton therapy is driven by its efficacy in treating complex and localized tumors, improving survival rates and quality of life. This precision makes it particularly valuable for pediatric cancers, where minimizing long-term side effects is crucial. The application of proton therapy extends to several cancer types, including brain, breast, lung, and prostate cancers, making it a flexible treatment across oncology. The end-use scope primarily spans hospitals, proton therapy centers, and specialized cancer research institutes. Market growth is fueled by technological advancements, awareness of treatment benefits, and increased healthcare spending. Developing regions offer untapped potential as they strive to modernize healthcare infrastructure. The rising prevalence of cancer and growing geriatric populations are significant growth drivers. However, challenges include high installation and maintenance costs, logistical complexities, and limited availability of facilities, especially in emerging markets. There is also a need for improved reimbursement scenarios to enhance accessibility. Enhancing research in beam delivery systems and exploring compact, lower-cost proton therapy systems represent innovation and growth areas. Collaborations between healthcare providers and technology firms could facilitate these advancements. The market’s nature is competitive yet niche, with potential for substantial growth as the technology becomes more widely adopted. Various stakeholders should focus on expanding public education and improving operational efficiencies to optimize outcomes. To capitalize on opportunities, businesses need to invest in reducing costs and streamlining treatment processes, partnering with insurance entities to develop better coverage models. Despite the obstacles, the proton therapy market holds promise for those ready to innovate and expand patient accessibility, indicating a ripe area for strategic focus and investment.

Understanding Market Dynamics in the Proton Therapy Market

The Proton Therapy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidences of cancers and tumors across the world
    • Expansion of cancer care facilities and growing awareness about the need for effective cancer treatments
    • Favorable government and regulatory support for proton therapy
  • Market Restraints
    • Need for specialized personnel for proton therapy treatment
  • Market Opportunities
    • Ongoing research and advancements to improve the efficacy and effectiveness of proton therapy
    • Possibility of combination of proton therapy with other cancer treatment strategies
  • Market Challenges
    • Complexities of side effects and efficacy issues

Exploring Porter’s Five Forces for the Proton Therapy Market

Porter’s Five Forces framework further strengthens the insights of the Proton Therapy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Proton Therapy Market

External macro-environmental factors deeply influence the performance of the Proton Therapy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Proton Therapy Market

The Proton Therapy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Proton Therapy Market

The Proton Therapy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Proton Therapy Market

The Proton Therapy Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Proton Therapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Oncotherapy PLC, Elekta AB, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Medaustron, Mevion Medical Systems, Inc., Mitsubishi Electric Corporation, Optivus Proton Therapy, Inc., Panacea Medical Technologies Pvt Ltd., Philips Healthcare, ProNova Solutions, LLC, ProTon International, Protonic Medical Systems Private Limited, Provision Healthcare, LLC, PTW Freiburg GmbH, RaySearch Laboratories AB, Sumitomo Heavy Industries Ltd., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Proton Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Equipment
      • Accelerator
      • Beam Delivery System
      • Beam Transport System
      • Nozzle & Image Viewers
      • Patient Positioning System
    • Services
    • Software
  • System Type
    • Multi-Room System
    • Single Room System
  • Therapy
    • Conventional Proton Therapy
    • Pencil Beam Scanning
  • Application
    • Colorectal Cancer
    • Lung Cancer
    • Pediatric Cancer
    • Prostate Cancer
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Proton Therapy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in tobacco consumption along with increase in number of cancer patients
5.1.1.2. Increasing life expectancy of people along with rise in geriatric population
5.1.1.3. Growing popularity of proton therapy
5.1.2. Restraints
5.1.2.1. High cost required for the installation of proton therapy centre
5.1.2.2. Lack of reimbursement policy
5.1.3. Opportunities
5.1.3.1. Rising number of proton therapy research programs in the developing market
5.1.3.2. Technological advancement in therapeutic systems of cancer treatments
5.1.4. Challenges
5.1.4.1. Lack of awareness in patients about proton therapy in the emerging economy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Proton Therapy Market, by System Type
6.1. Introduction
6.2. Multi-Room System
6.3. Single Room System
7. Proton Therapy Market, by Application
7.1. Introduction
7.2. Colorectal Cancer
7.3. Lung Cancer
7.4. Pediatric Cancer
7.5. Prostate Cancer
8. Proton Therapy Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Proton Therapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Proton Therapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Proton Therapy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accuray Incorporated
13.1.2. Advanced Oncotherapy PLC
13.1.3. Hitachi Ltd.
13.1.4. Ion Beam Applications SA
13.1.5. Koninklijke Philips N.V.
13.1.6. Mevion Medical Systems, Inc.
13.1.7. Mitsubishi Electric Corporation
13.1.8. Optivus Proton Therapy, Inc.
13.1.9. ProNova Solutions, LLC
13.1.10. ProTon International
13.1.11. Protonic Medical Systems Private Limited
13.1.12. Provision Healthcare, LLC
13.1.13. PTW Freiburg GmbH
13.1.14. Radiological Society of North America, Inc
13.1.15. RaySearch Laboratories AB
13.1.16. Sumitomo Heavy Industries Ltd.
13.1.17. Thermo Fisher Scientific, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PROTON THERAPY MARKET RESEARCH PROCESS
FIGURE 2. PROTON THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. PROTON THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROTON THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PROTON THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PROTON THERAPY MARKET DYNAMICS
FIGURE 7. PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2030 (%)
FIGURE 8. PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PROTON THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PROTON THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PROTON THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. PROTON THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PROTON THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PROTON THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 6. PROTON THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PROTON THERAPY MARKET SIZE, BY SINGLE ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. PROTON THERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PROTON THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PROTON THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PROTON THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 14. PROTON THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PROTON THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PROTON THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. PROTON THERAPY MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Proton Therapy market, which are profiled in this report, include:
  • Accuray Incorporated
  • Advanced Oncotherapy PLC
  • Elekta AB
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips N.V.
  • Medaustron
  • Mevion Medical Systems, Inc.
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy, Inc.
  • Panacea Medical Technologies Pvt Ltd.
  • Philips Healthcare
  • ProNova Solutions, LLC
  • ProTon International
  • Protonic Medical Systems Private Limited
  • Provision Healthcare, LLC
  • PTW Freiburg GmbH
  • RaySearch Laboratories AB
  • Sumitomo Heavy Industries Ltd.
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information